Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by mdjbrown


V.GSP

RE:RE:RE:RE:Potash mining in Kazakhstan - honorable mention to Gsp

sw248, I am not sure much credence can be given to the current bids and asks...

November 20, 2023

T.LABS

Agree 100% s1i

For those willing to wait, I think there is tremendous international news...

November 20, 2023

V.GSP

RE:RE:Potash mining in Kazakhstan - honorable mention to Gsp

You are welcome s248 Was hoping there might have been an opportunity for a...

November 17, 2023

T.LABS

Interesting take on another investment blog

"I finally listened to the recorded conference call. The company is...

November 17, 2023

T.LABS

Clearly Apotex was thinking way ahead back in 2018 when

they partnered with CannTrust for their CBD capabilities, so did Medipharm...

November 14, 2023

T.LABS

RE:RE:RE:RE:RE:RE:Sounds like the ANDA submission for generic Epidiolex

Would be nice to hear from the CEO regarding who the partner is alleyesonme...

November 14, 2023

T.LABS

It would appear the majority of the defendants in

the GW patent infringement lawsuits are arguing this patent as unenforceable,...

November 14, 2023

T.LABS

RE:RE:RE:RE:Sounds like the ANDA submission for generic Epidiolex

I think you are bang on s1i, and as this GW patent infringement claim...

November 14, 2023

T.LABS

RE:RE:Sounds like the ANDA submission for generic Epidiolex

Agree 100% s1i   The quarter to quarter increases in revenue...

November 14, 2023

T.LABS

Sounds like the ANDA submission for generic Epidiolex

by Medipharms partner was confirmed in the conference call. Maybe the folks...

November 14, 2023

T.LABS

Its only a matter of time before positive results appear

https://factsaboutcbd.org/medipharm-labs-corp-otcmkts-medif-completes-a-drug...

November 13, 2023

T.LABS

Will there be updates on the many trials Medipharm is

currently involved with in Q3 disclosure?  With Medipharms recent FDA...

November 11, 2023

V.GSP

Potash mining in Kazakhstan - honorable mention to Gsp

The Saskatchewan attendees in attendance, were the brainpower of Saskatchewan...

November 10, 2023

T.LABS

Looking forward to results from this study

Medipharm is involved in.  Could be life changing for so many suffering...

November 10, 2023

T.LABS

RE:Check out Aurora's performance, mdj...Australia and Europe's

Very impressive s1i, and I hope it reflects in Medipharms Q3 medical segment...

November 9, 2023

T.LABS

RE:RE:RE:mdj...I have absolutely no concerns or worries w.r.t. LABS

Lot of global factors to consider that out trump drama ........... https...

November 9, 2023

T.LABS

Interesting read from another investment site

Thank you Lemoyne  https://www.headset.io/brands/medipharm-labs

November 8, 2023

T.LABS

RE:mdj...I have absolutely no concerns or worries w.r.t. LABS

Agree s1i The world is an absolute mess right now and those in charge better...

November 8, 2023

T.LABS

RE:mdjbrown....while reading one of your posts, Athea double

Agree 100% s1i There is far more going on behind the scenes than just a...

November 8, 2023

T.LABS

RE:RE:RE:RE:Epidiolex infringement timelines

No worries s1. One thing you can be sure of is the timelines regarding...

November 8, 2023